NewLink Genetics Competitors and Similar CompaniesClear all

NewLink Genetics's competitors and similar companies include Calithera Biosciences and Immodulon Therapeutics.
NewLink Genetics
NewLink Genetics
NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.
Calithera Biosciences
Calithera Biosciences
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Immodulon Therapeutics
Immodulon Therapeutics
Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.
Founding Date
Founding Date
1999
Founding Date
2010
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Ames, US HQ
Austin, US
Devens, US
Locations
South San Francisco, US HQ
Locations
Hayes, GB HQ
London, GB
Employees
Employees
2162% decrease
Employees
798% increase
Employees
10
Valuation ($)
Valuation ($)
33.2 m
Valuation ($)
29.2 k
Valuation ($)
N/A

Financial

Net income
Net income
($30.4m) (FY, 2021)
Net income
($39.7m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 45.2m
Total funding raised
$ 105m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

View company
Immodulon Therapeutics
HQ
Hayes, GB
Employees
10

Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.

View company